Post-effective amendment to a registration statement that is not immediately effective upon filing

Subsequent Events (Detail Textuals)

v3.19.3.a.u2
Subsequent Events (Detail Textuals) - USD ($)
 1 Months Ended 12 Months Ended
Dec. 20, 2019
Dec. 19, 2019
Nov. 20, 2019
Feb. 28, 2019
Feb. 01, 2019
Jan. 31, 2019
Feb. 16, 2018
Jan. 19, 2018
Dec. 31, 2017
Sep. 30, 2019
Dec. 31, 2018
Mar. 31, 2017
Subsequent Event [Line Items]                        
Value of warrants issued                 $ 145,200      
Par value of common stock issued                 $ 0.001 $ 0.001 $ 0.001 $ 0.001
Securities Purchase Agreement | Emerald Health Sciences Inc                        
Subsequent Event [Line Items]                        
Common stock issued             15,000,000 15,000,000        
Number of warrants issued             20,400,000 20,400,000        
Warrant exercise price             $ 0.10 $ 0.10        
Term of warrant             5 years          
Subsequent Event | Pharmaceuticals International, Inc. Agreement                        
Subsequent Event [Line Items]                        
Estimated initial payment for contract           $ 72,500            
Subsequent Event | RRD International Agreement                        
Subsequent Event [Line Items]                        
Amount of payments due under the contract           78,680            
Amount of pass through expenses and consulting fees           $ 22,000            
Subsequent Event | 2nd Draw on Multi Draw Credit Facility                        
Subsequent Event [Line Items]                        
Value of warrants issued         $ 2,000,000              
Number of warrants issued         2,500,000              
Warrant exercise price         $ 0.50              
Subsequent Event | Noramco Agreement                        
Subsequent Event [Line Items]                        
Upfront payment       $ 146,386                
Subsequent Event | Independent Contractor Services Agreement | Dr. Avtar Dhillon                        
Subsequent Event [Line Items]                        
Monthly fee   $ 10,000                    
Monthly fee paid each month   5,000                    
Monthly fee accruing from effective date   $ 5,000                    
Subsequent Event | Warrant Exercise Agreement | Emerald Health Sciences Inc                        
Subsequent Event [Line Items]                        
Number of warrants exercised 40,800,000                      
Aggregate exercise price of warrants $ 4,080,000                      
Remaining balance of credit facility $ 2,014,500                      
Subsequent Event | Securities Purchase Agreement                        
Subsequent Event [Line Items]                        
Gross offering price for sale of securities     $ 2,000,000                  
Common stock issued     8,000,000                  
Par value of common stock issued     $ 0.001                  
Sale of stock, price per share     $ 0.25                  
Number of warrants issued     8,000,000                  
Warrant exercise price     $ 0.35                  
Term of warrant     5 years